Close

Imperial Capital Reiterates Outperform on Imperva (IMPV) Following 2Q Preliminary Results

July 13, 2016 7:10 AM EDT Send to a Friend
Imperial Capital reiterated an Outperform rating and $55.00 price target on Imperva (NYSE: IMPV) following the company's 2Q preliminary results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login